Heng Shen And Fubon Completed The Delivery Of Shares And Became The Largest Caprolactam Production Group In The World.

On the morning of October 30th, Holland time.

(hereinafter referred to as "Heng Shen") and fubant holding company (hereinafter referred to as "fubunt")

。

After this paction, Heng Shen owns fubunt.

as well as

Become a leap

And take the lead in opening up a complete industrial chain with 8 links.

It is understood that caprolactam referred to as CPL, mainly through polymerization to produce polyamide 6 chips, can be further processed into polyamide fiber, engineering plastics, plastic film, it is widely used in machinery, automobile, chemical equipment, aviation, metallurgy and other fields, is one of the important organic chemical raw materials.

Heng Shen holding group is a company from Shen Yuan.

The modern enterprise group composed of Heng Shen synthetic fiber, Li Heng nylon, Liyuan nylon and many other solid enterprises has taken the lead in the whole industry chain layout of caprolactam to dyeing and finishing in the world.

In July 2017, Shen Yuanxin Materials Co., Ltd. produced an annual output of 400 thousand tons of caprolactam and polyamide integrated project successfully launched and successfully put into operation. Caprolactam production ranks fourth in the world.

Forbont has devoted himself to the production of high quality caprolactam and ammonium sulphate for 66 years. It is the largest caprolactam production company in the world. It belongs to the world-famous Royal DSM group in Holland.

Fubon, which has world-renowned product quality, after-sales service and sustainable patents, is a leading supplier of famous engineering plastics manufacturers such as BASF, DSM, lanxon and downer. The engineering plastics produced by these companies are widely used in terminal production such as Mercedes Benz, BMW, Audi and so on.

In this paction, Heng Shen bought the 280 thousand tons of caprolactam production plant, 320 thousand tons of phenol cyclohexanone production plant, and 400 thousand tons caprolactam production plant of the Fubon Nanjing plant in Europe.

Production technology, phenol cyclohexanone production process and ammonium sulfate large particle production technology and other core technologies and intellectual property rights.

Forbont CEO Pol Deturck said that he had experienced a prudent process before the merger and acquisition, and that the cooperation between Heng Shen and Fu Bang has a long history. He is the biggest caprolactam customer, and more importantly, both sides are based on high quality, reliability and stability.

Forbt is pleased to be part of a thriving global operator in the field of caprolactam and nylon, which has strengthened Forbont's position in the challenging market, and believes that in the new family of Heng Shen, fubant will continue to shine.

In fact, as early as 2013, there was deep cooperation between Heng Shen and DSM.

DSM just developed the advanced production process of caprolactam HPO plus.

Heng Shen applied this technology to "thirst for technology". In that year, Shen Yuanxin Materials Co., Ltd. signed a strategic cooperation agreement with the Royal DSM group in Holland. It bought 400 thousand tons of caprolactam technology license with 1 billion yuan to the other party, and obtained exclusive exclusivity of the technology in Asia, providing a foreshadowing for future acquisitions.

In September 2015, DSM paid off the caprolactam business in consideration of strategic pformation and sold 65% of caprolactam to CVC equity fund.

In 2017, Heng Shen holding group became the first choice for CVC equity fund because of its successful caprolactam production experience and perfect industrial advantages. Finally, the two sides reached the purchase agreement of caprolactam business.

The world's fourth reverse takeover is the world's largest. The scale of Heng Shen caprolactam is the largest in the world. At that time, it has three major production bases in Lianjiang, Nanjing and Europe. Caprolactam has an annual capacity of 1 million 80 thousand tons, forming a new global chemical industry cluster with caprolactam production as the core.

Chen Jianlong, chairman of the board, said that through the acquisition, Heng Shen took the lead in opening up the complete industrial chain of cyclohexanone caprolactam polymerization - spinning - warping - warping - weaving - dyeing and finishing.

The most important thing is to have the cutting-edge production technology of caprolactam, to make up for the gaps of many technologies in China, to break the situation of related technology being controlled by others, to achieve all-round control of the whole nylon industry chain, and greatly enhance the pricing power and brand pricing power of Chinese enterprises in the caprolactam field, to a certain extent, to boost the whole industry to achieve a new level of Chinese manufacturing.

Heng Shen will take this opportunity to make use of the vision of European companies and the talents of globalization for the country.

Mining more advanced technology, and by self digestion, improve their technological innovation capability, and then promote the entire industry technological progress and pformation and upgrading.